CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net loss	$ (1,349,000,000)	$ (1,593,000,000)
Depreciation and amortization	188,000,000	118,000,000
Stock-based compensation	183,000,000	317,000,000
Inventory write-downs and losses on firm purchase commitments	229,000,000	188,000,000
Other non-cash activities	2,000,000	47,000,000
Changes in operating assets and liabilities:
Accounts receivable	(55,000,000)	4,000,000
Inventory	(781,000,000)	(367,000,000)
Other current assets	(11,000,000)	11,000,000
Other non-current assets	(18,000,000)	(6,000,000)
Accounts payable and accrued liabilities	22,000,000	201,000,000
Other current liabilities	15,000,000	40,000,000
Other non-current liabilities	54,000,000	6,000,000
Net cash used in operating activities	(1,521,000,000)	(1,034,000,000)
Cash flows from investing activities:
Capital expenditures	(283,000,000)	(418,000,000)
Net cash used in investing activities	(283,000,000)	(418,000,000)
Cash flows from financing activities:
Proceeds from issuance of capital stock	3,000,000	1,000,000
Proceeds from issuance of convertible notes	1,485,000,000	0
Other financing activities	(3,000,000)	(1,000,000)
Net cash provided by financing activities	1,485,000,000	0
Net change in cash	(319,000,000)	(1,452,000,000)
Cash, cash equivalents, and restricted cash—Beginning of period	12,099,000,000	18,423,000,000
Cash, cash equivalents, and restricted cash—End of period	11,780,000,000	16,971,000,000
Supplemental disclosure of non-cash investing and financing activities:
Capital expenditures included in liabilities	333,000,000	406,000,000
Capital stock issued to settle bonuses	137,000,000	0
Right-of-use assets obtained in exchange for operating lease liabilities	$ 11,000,000	$ 54,000,000